HMGB1 and early-onset autosomal dominant Alzheimer disease: Analyzing four models of frontotemporal lobar degeneration and four models of Alzheimer’s disease, they observe conserved signaling networks and confirm a therapeutic effect of human anti-HMGB1, demonstrating the utility of the approach.